Seroxat
EDM number 568 in 2003-04, proposed by Paul Flynn on 05/02/2004.
That this House expresses concern at the tragic deaths associated with the anti-depressant drug Seroxat and the news that GlaxoSmithKline suppressed news of two 1998 studies that demonstrated that the drug was no more effective than placebos; notes with alarm the Department of Health's view that Seroxat can make the symptoms of depression more severe and the decision of a court that Seroxat was responsible for a change in the behaviour of a man who took his own life and that of his family; and calls for a full investigation of the conduct of GlaxoSmithKline who appear to have put their private greed before public safety.
This motion has been signed by a total of 65 MPs, 1 of these signatures have been withdrawn.
Download raw data as csv or xml.